Latest / Morning Medical with Dr. Chow / Microplastics in Health, GLP-1 Drug Effects, and Superagers' Secrets

Transcript

Microplastics in Health, GLP-1 Drug Effects, and Superagers' Secrets · Morning Medical with Dr. Chow

• 0:00
  Welcome to Morning Medical with Dr.
• 0:02
  Chow, your daily update on the latest medical and health news from around the world, powered
• 0:07
  by artificial intelligence.
• 0:08
  I’m Dr.
• 0:10
  Chi-Ming Chow, a family physician, general internist, and cardiologist, here to bring you
• 0:15
  the most recent developments in healthcare.
• 0:17
  Today, we'll be discussing a significant study that has identified microplastics in the blood
• 0:21
  of heart attack patients, a finding that could have implications for how we understand
• 0:25
  cardiovascular health.
• 0:30
  A recent study published in the European Heart Journal has revealed that microplastics, those
• 0:36
  tiny plastic particles that are less than five millimeters in size, have been detected in the
• 0:42
  blood of a significant number of patients experiencing severe heart attacks.
• 0:48
  This startling discovery was made by a team of Italian researchers led by Dr.
• 0:54
  Raffaele Marfella from the University of Campania Luigi Vanvitelli in Naples.
• 1:01
  The researchers analyzed blood samples from 61 patients who were undergoing angiograms, a
• 1:07
  procedure used to check for irregularities in blood vessels.
• 1:11
  They found that nearly 84 percent of those suffering from an active, severe heart attack
• 1:16
  had detectable levels of micro- and nanoplastics in their blood.
• 1:21
  In contrast, these particles were found in only 40 percent of patients with chronic heart
• 1:26
  disease and 32 percent of those with normal coronary arteries.
• 1:31
  Polyethylene, a common plastic used in bags and bottles, was the most frequently detected type
• 1:38
  of plastic, appearing in 97 percent of those who tested positive for microplastics.
• 1:44
  The presence of these particles in the blood of heart attack patients suggests a potential link
• 1:49
  between microplastic exposure and cardiovascular events, although it's important
• 1:54
  to note that the study does not establish a direct cause and effect relationship.
• 1:59
  Michelle Routhenstein, a preventive cardiology dietitian, highlighted that while the findings
• 2:05
  are intriguing, they should be seen within the broader context of environmental health risks.
• 2:11
  She pointed out that other factors like smoking and air pollution are also linked to both
• 2:16
  cardiovascular disease and increased exposure to plastics, complicating the ability to
• 2:21
  separate the independent effects of microplastics.
• 2:25
  The study also found that a history of smoking was the strongest predictor of detectable
• 2:30
  plastic particles in the blood, suggesting that lifestyle factors may play a significant role
• 2:36
  in microplastic exposure.
• 2:39
  This observation underscores the complexity of environmental and health variables that need to
• 2:44
  be considered in this area of research.
• 2:48
  To mitigate potential risks associated with microplastic exposure, experts recommend making
• 2:53
  simple lifestyle changes.
• 2:55
  For instance, using glass or ceramic containers instead of plastic for food storage and heating
• 3:01
  can reduce exposure.
• 3:03
  Additionally, limiting the use of plastic water bottles, especially when exposed to heat, may
• 3:08
  also be beneficial.
• 3:10
  While more research is needed to fully understand the implications of microplastics in
• 3:15
  cardiovascular health, this study adds an important piece to the puzzle.
• 3:20
  As always, maintaining a heart-healthy lifestyle, which includes reducing plastic
• 3:25
  exposure, is advisable.
• 3:29
  A new study published in the British Medical Journal has identified a potential link between
• 3:34
  the use of glucagon-like peptide-1 receptor agonists, commonly known as GLP-1 drugs, and an
• 3:41
  increased risk of hair loss.
• 3:43
  These drugs, including popular names like Ozempic and Wegovy, are primarily used to
• 3:48
  manage Type 2 diabetes and aid in weight loss.
• 3:52
  The study observed over fifty thousand individuals with Type 2 diabetes who were
• 3:56
  taking GLP-1 receptor stimulants.
• 4:00
  Researchers compared these patients with those using other diabetes medications, such as
• 4:05
  sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors.
• 4:11
  It was found that patients on GLP-1 drugs had a thirty-seven percent higher risk of developing
• 4:18
  alopecia compared to those on sodium-glucose cotransporter-2 inhibitors, and a sixty-eight
• 4:24
  percent higher risk compared to those using dipeptidyl peptidase-4 inhibitors.
• 4:29
  Despite these figures, the actual incidence of alopecia was relatively low, ranging from
• 4:35
  approximately three to nine cases per one thousand people annually.
• 4:40
  The study emphasizes that while the absolute risk is small, awareness of this potential side
• 4:46
  effect is crucial for making informed treatment decisions.
• 4:50
  Dr.
• 4:51
  Elena Netchiporouk, a regional director with the Canadian Dermatology Association, explained
• 4:57
  that rapid weight loss often associated with GLP-1 drugs can lead to temporary hair loss.
• 5:03
  This is because the body, when experiencing stress from quick weight changes, prioritizes
• 5:09
  essential functions over hair and nail growth.
• 5:13
  The study suggests that hair loss may not be directly caused by the drugs themselves
• 5:17
  damaging hair follicles.
• 5:20
  Instead, it may relate to broader metabolic, hormonal, and immunological effects of GLP-1
• 5:27
  receptor agonists that influence hair follicle growth and cycling.
• 5:32
  Dr.
• 5:32
  Netchiporouk noted that rapid weight loss signals the body that something is amiss,
• 5:37
  leading to a temporary halt in hair growth, typically lasting about six months.
• 5:44
  In some cases, gastrointestinal symptoms from these medications, such as nausea and vomiting,
• 5:50
  can contribute to nutritional deficiencies, further impacting hair health.
• 5:56
  The U.S.
• 5:57
  Food and Drug Administration has acknowledged reports of hair loss following the use of GLP-1
• 6:03
  receptor agonists, particularly semaglutide and tirzepatide, used in drugs like Wegovy,
• 6:08
  Ozempic, and Mounjaro.
• 6:11
  While hair loss is not physically harmful, it can have significant psychosocial effects,
• 6:16
  impacting self-esteem and quality of life.
• 6:20
  Dr.
• 6:20
  Netchiporouk advises patients to avoid losing weight too quickly and to consider starting
• 6:26
  with lower doses of GLP-1 drugs to allow the body to adjust.
• 6:30
  This approach may help in minimizing the risk of hair loss while still benefiting from the
• 6:36
  therapeutic effects of these medications.
• 6:40
  Our final segment today takes us into the fascinating world of aging and memory.
• 6:45
  A new study has revealed that superagers, who are individuals aged 80 or older with
• 6:51
  exceptional memory, do not owe their cognitive prowess solely to their genetic makeup.
• 6:58
  This research, published in Alzheimer's Research & Therapy, challenges the long-held
• 7:03
  belief that genes are the primary factor in determining one's cognitive abilities in later
• 7:09
  life.
• 7:10
  The study was conducted by Ignazio Stefano Piras, Ph.D., from the Translational Genomics
• 7:17
  Research Institute at City of Hope in Phoenix, along with his colleagues.
• 7:21
  They assessed a group of superagers and compared them with cognitively average older
• 7:26
  adults.
• 7:27
  Surprisingly, they found no significant differences in the genetic profiles between
• 7:32
  these two groups, particularly in genes like APOE, which are commonly associated with
• 7:37
  Alzheimer's disease risk.
• 7:40
  APOE, especially the APOE4 allele, is known to increase the risk of Alzheimer's, while APOE2
• 7:46
  is thought to be protective.
• 7:48
  However, the study found that the distribution of these alleles was similar between superagers
• 7:55
  and their cognitively average counterparts.
• 7:59
  This suggests that genes alone cannot explain why some people maintain exceptional memory
• 8:03
  well into their 80s and beyond.
• 8:06
  The researchers also looked at three polygenic risk scores for Alzheimer's disease, as well as
• 8:12
  rare protective genetic variants, but none of these factors predicted who would become a
• 8:17
  superager.
• 8:18
  This finding underscores the idea that lower genetic risk for Alzheimer's might be common
• 8:23
  among those who age successfully, but it's not enough to account for the superagers'
• 8:29
  extraordinary memory.
• 8:31
  The study points out that while identifying risk factors for Alzheimer's is crucial, the
• 8:36
  absence of these risks does not automatically mean an individual has the protective factors
• 8:41
  necessary for exceptional cognitive health.
• 8:43
  The researchers emphasize that other factors, possibly including lifestyle, social
• 8:48
  engagement, and brain morphology, might play significant roles in superaging.
• 8:54
  It's interesting to note that superagers often display a thicker cingulate gyrus,
• 8:58
  better-preserved cholinergic innervation, and fewer Alzheimer's-related brain changes.
• 9:04
  These biological characteristics, alongside social attributes like being gregarious, may
• 9:09
  contribute to their cognitive resilience.
• 9:12
  This study highlights the complexity of aging and suggests that a combination of genetic,
• 9:17
  biological, and social factors contribute to maintaining cognitive health.
• 9:22
  As we wrap up today's episode, it's clear that the journey to understanding superagers is far
• 9:29
  from over.
• 9:31
  This research opens new avenues for exploring how we can all strive for cognitive health as
• 9:36
  we age, beyond just our genetic predispositions.
• 9:41
  Thank you for tuning in to Morning Medical with Dr.
• 9:44
  Chow.
• 9:45
  Stay healthy and keep your curiosity alive.
• 9:48
  Until next time, take care.